SOURCE: Alexium Inc.

Alexium Inc.

June 01, 2015 11:54 ET

Alexium Receives Purchase Order for Scale Up Production Trial From New Client in European Transportation Sector

PERTH, AUSTRALIA and GREER, SC--(Marketwired - Jun 1, 2015) - Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) is pleased to announce it has received a purchase order for fire retardant (FR) formulations from a new customer in the transportation/automotive market. We will immediately begin working with this client to scale-up our chemistries in their facility for a commercial production run trial.

The customer is a manufacturer of high quality textiles for the European luxury automotive sector and has demonstrated a commitment to environmentally-friendly solutions for its products.

We estimate that the potential revenue opportunity for this client, for annual consumption of FR chemistry, to be in the order of $10-15 million annually.

"This is an exciting development for Alexium. We are progressing a further footprint in the European marketplace with a highly regarded customer in terms of their product, their end use customer automotive brands, and their commitment to the environment," stated Nicholas Clark, CEO and Executive Director.

Alexium will provide further information on this customer as trials progress.

For more information visit: www.alexiuminternational.com.

About Alexium
Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatment are currently marketed for different fabric markets under the Alexiflam™, Alexiflam-NF™, Alexiflam-SYN™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.

Contact Information

  • U.S. Contact:
    Julie Patrick
    Marketing & PR Specialist
    jpatrick@alexiuminternational.com
    U.S.: +1 864.908.6793

    U.S. R&D Center:
    8 Distribution Court
    Greer, SC 29650
    T: +1 864.416.1060
    F: +1 864.752.6465

    U.S. Corporate Office:
    148 Milestone Way
    Greenville, SC 29615
    T: +1 864.603.1165
    F: +1 864.752.6465